This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma
risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further …

Pancreatic cancer is one of the leading causes of cancer-related mortality in western
countries. Early diagnosis of pancreatic cancers plays a key role in the management by …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, characterized
by rapid progression, metastasis, and difficulty in diagnosis. However, there are no effective …

Cancer is one of the major causes of mortality worldwide and its already large burden is
projected to increase significantly in the near future with a predicted 22 million new cancer …

Simple Summary A highly desirable approach to diagnose a human disease quickly and
easily is to identify a chemical, protein, or antibody in a biofluid like blood or urine that is …

Pancreatic ductal adenocarcinoma (PDAC) is often detected too late to allow adequate
treatments with the result that patients are condemned to sufferings and early death. Most …

Our study aimed to identify a urinary metabolite panel for the detection/diagnosis of
pancreatic ductal adenocarcinoma (PDAC). PDAC continues to have poor survival …

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with five-year
survival rates around 10%. The only curative option remains complete surgical resection, but …

Pancreatic ductal adenocarcinoma (PDAC) is an incredibly deadly disease with a 5-year
survival rate of 9%. The presence of pancreatic cystic lesions (PCLs) confers an increased …

Objective High-dose prednisone use, lasting several months or longer, is the primary initial
therapy for myasthenia gravis (MG). Upwards of a third of patients do not respond to …